Biochemical Analysis of Caur SOD4, a Potential Therapeutic Target for the Emerging Fungal Pathogen Candida auris
is an emerging multidrug-resistant fungal pathogen. With high mortality rates, there is an urgent need for new antifungals to combat . Possible antifungal targets include Cu-only superoxide dismutases (SODs), extracellular SODs that are unique to fungi and effectively combat the superoxide burst of...
Gespeichert in:
Veröffentlicht in: | ACS infectious diseases 2022-03, Vol.8 (3), p.584-595 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | is an emerging multidrug-resistant fungal pathogen. With high mortality rates, there is an urgent need for new antifungals to combat
. Possible antifungal targets include Cu-only superoxide dismutases (SODs), extracellular SODs that are unique to fungi and effectively combat the superoxide burst of host immunity. Cu-only SODs are essential for the virulence of diverse fungal pathogens; however, little is understood about these enzymes in
We show here that
secretes an enzymatically active Cu-only SOD (
SOD4) when cells are starved for Fe, a condition mimicking host environments. Although predicted to attach to cell walls,
SOD4 is detected as a soluble extracellular enzyme and can act at a distance to remove superoxide.
SOD4 selectively binds Cu and not Zn, and Cu binding is labile compared to bimetallic Cu/Zn SODs. Moreover,
SOD4 is susceptible to inhibition by various metal-binding drugs that are without effect on mammalian Cu/Zn SODs. Our studies highlight
SOD4 as a potential antifungal target worthy of consideration. |
---|---|
ISSN: | 2373-8227 2373-8227 |
DOI: | 10.1021/acsinfecdis.1c00590 |